Clinical Study
The Therapeutic Effectiveness of the Coadministration of Weekly Risedronate and Proton Pump Inhibitor in Osteoporosis Treatment
Table 1
Adverse events occurred under medical treatment.
| | BP | | BP + PPI | |
| | Stomachache | 2 | Stomachache | 1 | | Constipation | 1 | Heavy stomach feeling | 1 | | Gingival bleeding | 1 | Constipation | 1 | | Drowsiness | 1 | Double vision | 1 | | Reflux esophagitis | 1 | Ileus | 1 | | Neck discomfort | 1 | Leukopenia | 1 | | Gaseous regurgitation | 1 | Vertebral fracture | 2 | | Urticaria | 1 | Nausea | 1 | | Vertebral fracture | 1 | | |
| | Total number of adverse events | 10 | | 9 |
|
|
